Interleukin 10 (IL-10) regulation of tumour necrosis factor α (TNF-α) from human alveolar macrophages and peripheral blood monocytes

Thorax

Volumn 51, Issue 2, 1996, Pages 143-149

  Armstrong, Lynne ^a   Jordan, Nicola ^b   Millar, Ann ^a  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

^b University of Bath   (United Kingdom)

Author keywords

Alveolar macrophage; Interleukin 10; Tumour necrosis factor regulation

Indexed keywords

INTERLEUKIN 10; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELLULAR IMMUNITY; GENE EXPRESSION REGULATION; HOST RESISTANCE; HUMAN; HUMAN CELL; LUNG ALVEOLUS MACROPHAGE; MONOCYTE; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

ADULT; BLOTTING, NORTHERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MACROPHAGES, ALVEOLAR; MONOCYTES; RECOMBINANT PROTEINS; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030064864     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.51.2.143     Document Type: Article

References (46)

1. Jacobs RF, Tabor DR, Burks AW, Campbell GD. Elevated IL-1 release by human alveolar macrophages during ARDS. Am Rev Respir Dis 1989;140:1686-92.
2. Miller EJ, Cohen AB, Nagao, S, Griffith D, Maunder RJ, Martin TR, et al. Elevated levels of NAP-1/IL-8 are present in the airspaces of patients with ARDS and are associated with increased mortality. Am Rev Respir Dis 1992;146: 427-32.
3. Tran Van Nhieu J, Misset B, Lebargy F, Carlet J, Bernaudin JF. Expression of TNF-α gene in alveolar macrophages from patients with ARDS. Am Rev Respir Dis 1993;147: 1585-89.
4. Carré PC, Mortenson RL, King TE, Noble PW, Sable CL, Riches DWH. Increased expression of the IL-8 gene by alveolar macrophages in idiopathic pulmonary fibrosis. J Clin Invest 1991;88:1802-10.
5. Zhang Y, Lee TC, Guillemin B, Yu M-C, Rom WN. Enhanced IL-1β and TNF-α release and mRNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure. J Immunol 1993;150:4188-96.
6. Foley NM, Millar AB, Meager A, Johnson McI N, Rook GAW. TNF production by alveolar macrophages in pulmonary sarcoidosis and tuberculosis. Sarcoidosis 1992;9: 29-34.
7. Shalaby MR, Aggarwal BB, Ainderknecht E, Svendersky LP, Finkle BS, Palladino Jr A. Activation of human polymorphonuclear functions by interferon-gamma and tumour necrosis factors. J Immunol 1985;135:2069-73.
8. Nawroth PP, Stern DM. Modulation of endothelial cell haemostatic properties by TNF. J Exp Med 1986;163: 740-5.
9. Horvath CJ, Ferro TJ, Jesmok G, Malik AB. Recombinant TNF increases pulmonary vascular permeability independent of neutrophils. Proc Natl Acad Sci USA 1988; 85:9219-23.
10. Vilcek J, Palombella VJ, Henriksen-DeStefano D, Swenson C, Feinman R, Hirai M, Tsuyimoto M. Fibroblast growth-enhancing activity of TNF and its relationship to other polypeptide growth factors. J Exp Med 1986;163:632-43.
11. Mantovani A, Dejana E. Cytokines as communication signals between leukocytes and endothelial cells. Immunol Today 1989;10:370-5.
12. Jablons DM, Mulé JJ, McIntosh JK, Sehgal PB, May LT, Huang CM, et al. IL-6/IFN-β-2 as a circulating hormone. J Immunol 1989;142:1542-7.
13. Matsushima K, Morishita K, Yoshimura T, Lavu S, Kobayashi Y, Lew W, et al. Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDCNF) and the induction of MDCNF mRNA by IL-1 and TNF. J Exp Med 1988;167:1883-9.
14. Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse helper T cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989;170:2081-95.
15. Viera P, de Waal Malefyt R, Dang MN, Johnson KE, Kastelein R, Fiorentino DF, et al. Isolation and expression of human cytokine synthesis inhibitor factor (CSIF/IL-10) cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI. Proc Natl Acad Sci USA 1991;88: 1172-8.
16. Yssel H, De Waal Malefyt R, Roncarolo M-G, Abrams JS, Lahesmaa R, Spits H, et al. IL-10 is produced by subsets of human CD4 + T cell clones and peripheral blood T-cells. J Immunol 1992;149:2378-84.
17. De Waal Malefyt R, Abrams J, Bennet B, Figdor CG, De Vries JE. IL-10 (IL-10) inhibits cytokine synthesis by human monocytes - an autoregulatory role for IL-10 produced by monocytes. J Exp Med 1991;174:1209-20.
18. Ding L, Shevach EM. IL-10 inhibits mitogen induced T-cell proliferation by selectively inhibiting macrophage co-stimulatory function. J Immunol 1992;148:3133-9.
19. Ding L, Linsley DS, Huang LY, Germain RN, Shervach EM. IL-10 inhibits macrophage co-stimulatory activity by selectively inhibiting the up-regulation of B7 expression. J Immunol 1993;151:1224-34.
20. De Waal Malefyt, R, Haanen J, Spits H, Roncarolo M-G, te Velde A, Figdor C, Johnson K, et al. IL-10 and viral IL-10 strongly reduced antigen specific human T-cell proliferation by diminishing the antigen presenting capacity of monocytes via down-regulation of class II major histocompatibility complex expression. J Exp Med 1991; 174:915-24.
21. Ralph P, Nakoinz I, Sampson-Johannes A, Fong S, Lowe D, Min H, Lin L. IL-10, T lymphocyte inhibitor of human blood cell production of Il-1 and TNF. J Immunol 1992; 148:808-14.
22. Cassatella MA, Meda L, Bonora S. Ceska M, Constantin G. IL-10 inhibits the release of pro-inflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of TNF and IL-1β in mediating the production of IL-8 triggered by LPS. J Exp Med 1993; 178:2207-11.
23. Jonas E, Sargent T, Dawid I. Epidermal keratin gene expressed in embryos of Xenopus laevis. Proc Natl Acad Sci USA 1985;82:5413-7.
24. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
25. Strieter RM, Phan SH, Showell HJ, Remick DG, Lynch JP, Genord M, et al. Monokine-induced neutrophil chemotactic factor gene expression in human fibroblasts. J Biol Chem 1989;264:10621-6.
26. Obrig TG, Gulp WJ, Mckeehan WL, Hordesty B. The mechanisms by which cyclohexamide and related glutamide antibiotics inhibit peptide synthesis on reticulocyte ribosomes. J Biol Chem 1971;246:174-8.
27. Sobell HM. Actinomycin D and DNA transcription. Proc Nat Acad Sci USA 1985;82:5328-31.
28. Piguet PF, Collart MA, Grau GE, Kapanci Y, Vassalli P. TNF/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis. J Exp Med 1989;170:655-63.
29. Tracey KJ, Fong Y, Hesse DG, Manogue KR, Lee AT, Kuo GC, et al. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethel bacteraemia. Nature 1987;330:662-4.
30. Nakane A, Minagawa T, Kohanawa M, Chen Y, Sato H, Moriyama M, et al. Interactions between endogenous gamma interferon and TNF in host resistance against primary and secondary Listeria monocytogenes infections. Infect Immun 1989;57:3331-7.
31. Elia J. Tumour necrosis factor interacts with IL-1 and interferon to inhibit fibroblast proliferation via fibroblast postoglandin-dependent and -independent mechanisms. Am Rev Respir Dis 1988;138:652.
32. Wanidworanun C, Strober W. Predonimant role of tumor necrosis factor-α in human monocyte IL-10 synthesis. J Immunol 1993;151:6853-61.
33. Beutler B, Krochin N, Milsark IW, Leudke C, Cerami A. Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science 1986;232: 977-80.
34. Han J, Beutler B, Huez G. Complex regulation of tumor necrosis factor mRNA turnover in lipopolysaccharide-activated macrophages. Biochim Biophys Acta 1991;1090: 22-8.
35. Strieter RM, Remick DG, Lynch III JP, Genord M, Raiford C, Spengler R, et al. Differential regulation of TNF-α in human AMs and PBMs: a cellular and molecular analysis. Am J Respir Cell Mol Biol 1989;1:57-63.
36. Martinet Y, Yamauchi K, Crystal RG. Differential expression of the tumor necrosis factor/cachectin gene by blood and lung mononuclear phagocytes. Ant Rev Respir Dis 1988; 138:659-65.
37. Beutler B, Cerami A. The biology of cachectin/TNF - primary mediator of the host response. Annu Rev Immunol 1989;7:625-55.
38. Han J, Brown T, Beutler B. Endotoxin-responsive sequences control cachectin tumour necrosis. Biosynthesis at the translational level. J Exp Med 1990;171:465-75.
39. Han J, Huez G, Beutler B. Interactive effects of the tumor necrosis factor promoter and 3′ untranslated regions. J Immunol 1991;146:1843-50.
40. Bogdan C, Paik J, Vodovotz Y, Nathan C. Contrasting mechanisms for the suppression of macrophage cytokine release by transforming growth factor-beta and interleukin-10. J Biol Chem 1992;267:23301-8.
41. Beutler B, Thompson P, Keyes J, Hagerty K, Crawford D. Assay of a ribonuclease that preferentially hydrolyses mRNAs containing cytokine-derived UA-rich instability sequences. Biochem Biophys Res Commun 1988;152:973-80.
42. Shaw G, Kamen R. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 1986;46:659-67.
43. Marchant A, Deviere J, Byl B, De Groote D, Vincent J-L, Goldman M. IL-10 production during septicaemia. Lancet 1994;343:707-8.
44. Katsikis PD, Chu C-Q, Brennan FM, Maini RM, Feldmann M. Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J Exp Med 1994;179:1517-27.
45. 2. Proc Natl Acad Sci USA 1989;86:3803-7.
46. De Waal Malefyt R, Figdor CG, Huijbens R, Mohan-Peterson S, Bennett B, Culpepper J, et al. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes: comparison with IL-4 and modulation by IFN-γ or IL-10. J Immunol 1993;151: 6370-81.